SHIP1 Inhibitors to Augment Blood Cell Production and Transplantation and Kill Cancer Cells SUNY Upstate Medical University researchers have developed a class of small molecule compounds that show promise for treating multiple myeloma and myelosuppression that occurs with many cancer treatments. These drugs inhibit a gene called SHIP1 — a novel target in cancer treatment — and have been shown to kill cancer cells in the lab and extend... Category(s): Technology Classifications > Biological Materials, Technology Classifications > Therapeutics and Vaccines